209
Participants
Start Date
April 12, 2017
Primary Completion Date
December 10, 2019
Study Completion Date
August 30, 2023
LY3321367
Administered IV
LY3300054
Administered IV
Columbia University College of Phys & Surgeons, New York
Memorial Sloan Kettering Cancer Center, New York
Fundación Jiménez Díaz-Oncology, Madrid
Hospital Madrid Norte Sanchinarro, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Sarah Cannon Research Institute SCRI, Nashville
Peggy and Charles Stephenson Oklahoma Cancer Center, Oklahoma City
University of Texas MD Anderson Cancer Center, Houston
The START Center for Cancer Care, San Antonio
The University of Arizona Cancer Center, Tucson
Dana Farber Cancer Institute, Boston
National Cancer Center Hospital East, Kashiwa
National Cancer Center Hospital, Chuo-Ku
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Eli Lilly and Company
INDUSTRY